https://www.selleckchem.com/pr....oducts/gi254023x.htm
14±0.02µmol/L and 4.2±0.2mmol/L in control muscles to 0.45±0.03µmol/L and 4.7±0.3mmol/L in muscles with 9-AC respectively (P.05, paired T test). Inhibition of acetylcholinesterase (neostigmine) and inhibition of voltage-gated K channels (4-AP) relieve symptoms in myasthenia gravis and Lambert-Eaton syndrome, respectively. Neostigmine and 9-AC additively increased the tubocurarine concentration required to reduce nerve-stimulated force to 50% (0.56±0.05µmol/L with 9-AC and neostigmine) and, similarly, 4-AP and 9-AC additively incre
Like
Comment
Share
